Jupiter Asset Management Ltd. Lowers Stake in Cardinal Health, Inc. $CAH

by · The Cerbat Gem

Jupiter Asset Management Ltd. reduced its stake in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 98.7% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,921 shares of the company’s stock after selling 294,962 shares during the quarter. Jupiter Asset Management Ltd.’s holdings in Cardinal Health were worth $806,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in CAH. Integrated Wealth Concepts LLC boosted its position in shares of Cardinal Health by 6.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 4,363 shares of the company’s stock worth $601,000 after purchasing an additional 280 shares in the last quarter. Jones Financial Companies Lllp boosted its position in shares of Cardinal Health by 198.3% in the 1st quarter. Jones Financial Companies Lllp now owns 21,112 shares of the company’s stock worth $27,000 after purchasing an additional 14,034 shares in the last quarter. Arrowstreet Capital Limited Partnership bought a new stake in shares of Cardinal Health in the 2nd quarter worth approximately $1,935,000. Cerity Partners LLC boosted its position in shares of Cardinal Health by 17.0% in the 2nd quarter. Cerity Partners LLC now owns 40,426 shares of the company’s stock worth $6,792,000 after purchasing an additional 5,880 shares in the last quarter. Finally, Nebula Research & Development LLC boosted its position in shares of Cardinal Health by 34.4% in the 2nd quarter. Nebula Research & Development LLC now owns 10,334 shares of the company’s stock worth $1,736,000 after purchasing an additional 2,646 shares in the last quarter. 87.17% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of analysts have recently commented on CAH shares. Citigroup dropped their price target on Cardinal Health from $249.00 to $245.00 and set a “buy” rating on the stock in a research report on Friday, May 1st. Morgan Stanley boosted their price target on Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research report on Tuesday, April 28th. JPMorgan Chase & Co. lowered their price objective on Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research report on Monday, May 4th. Evercore lowered their price objective on Cardinal Health from $260.00 to $240.00 and set an “outperform” rating on the stock in a research report on Wednesday, April 8th. Finally, TD Cowen upped their price objective on Cardinal Health from $251.00 to $255.00 and gave the company a “buy” rating in a research report on Friday, May 1st. One analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and two have assigned a Hold rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $241.80.

Check Out Our Latest Research Report on Cardinal Health

Cardinal Health Trading Down 1.6%

CAH stock opened at $196.57 on Friday. The stock has a market capitalization of $46.04 billion, a PE ratio of 30.06, a price-to-earnings-growth ratio of 1.17 and a beta of 0.53. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60. The stock’s 50 day simple moving average is $203.52 and its 200 day simple moving average is $208.79.

Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings data on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The business had revenue of $60.94 billion for the quarter, compared to analysts’ expectations of $62.10 billion. Cardinal Health had a negative return on equity of 92.61% and a net margin of 0.62%.The firm’s quarterly revenue was up 11.0% on a year-over-year basis. During the same period in the prior year, the firm posted $2.35 EPS. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. On average, research analysts predict that Cardinal Health, Inc. will post 10.76 earnings per share for the current year.

Cardinal Health Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.

Cardinal Health Profile

(Free Report)

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.

Featured Stories